Clinical trial
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed…
NCT00075712 · Royal College of Obstetricians and Gynecologists, Other · Completed
Key facts
| NCT number | NCT00075712 |
|---|---|
| Title | Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer |
| Official title | A Randomized Feasibility Trial to Determine the Impact of Timing of Surgery and Chemotherapy in Newly Diagnosed Patients With Advanced Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma |
| Lead sponsor | Royal College of Obstetricians and Gynecologists, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, paclitaxel, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 150 |
| Start date | Sep 1, 2003 |
| First posted | Jan 13, 2004 |
| Last update posted | Aug 12, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: